Stay informed with the latest litigation news. Explore now

IP Verse

Alfasigma competitive analysis

Latest publications and patents of Alfasigma New

Explore the latest publications and patents granted to Alfasigma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 13, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Alfasigma

EP3595667
Dec 20, 2023Pharmaceutical Compositions Comprising A Jak InhibitorGranted And Under Opposition
EP3439637
Jun 1, 2022Process For Mesalazine Solid FormulationsGranted And Under Opposition
EP3076958
Jan 10, 2018Composition Useful For Promoting Female FertilityNo Opposition Filed Within Time Limit
EP2618819
Nov 1, 2017Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal DiseaseRevoked
EP2560662
Jun 7, 2017Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are InvolvedRevoked
EP2059232
Apr 19, 2017Use Of Polyols To Obtain Stable Polymorphous Forms Of RifaximinGranted And Under Opposition

Latest oppositions filed by Alfasigma

Explore patent oppositions filed by Alfasigma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3536311
Storage Stable Composition Comprising Rifaximin AlphaSANDOZSep 22, 2022
EP3434265
Pharmaceutical Composition Containing Rifaximin Alpha & DeltaSANDOZMar 21, 2022
EP3416627
Oral Dosage Form Comprising Rifaximin In Form BetaSANDOZAug 27, 2020
EP3373914
Storage Stable Composition Comprising Rifaximin AlphaSANDOZJan 24, 2020
EP3294270
Pharmaceutical Composition Containing Rifaximin Alpha&DeltaSANDOZJun 12, 2019

Latest patents of Alfasigma opposed by its competitors

Explore Alfasigma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3595667
Dec 20, 2023Pharmaceutical Compositions Comprising A Jak Inhibitor3
EP3439637
Jun 1, 2022Process For Mesalazine Solid Formulations1
EP2618819
Nov 1, 2017Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease1
EP2560662
Jun 7, 2017Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved2
EP2059232
Apr 19, 2017Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin3

Latest PTAB cases involving Alfasigma New

Discover the latest PTAB cases involving Alfasigma, highlighting their recent legal challenges and patent disputes.

Top competitors of Alfasigma

Top competitors of Alfasigma based on patent oppositions.